Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma
Status:
Not yet recruiting
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of citicoline eye drops 2% in reducing visual field deterioration in
patients with progressing OAG treated according to best clinical practice. Secondary
objectives are assessing the effect of citicoline eye drops 2% on changes in structural
parameters measured by Spectral Domain Optical Coherence Tomography (SD-OCT) and evaluating
the safety of citicoline eye drops 2%